GLAM
MNTA

Gardner Lewis Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Gardner Lewis Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-629,772
Closed -$33M – 87
2020
Q3 		$33M Buy
+629,772
New +$26.1M 5.99% 3

Gardner Lewis Asset Management's MNTA Position: Q4 2020 in Review

Gardner Lewis Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 629,772 shares — an estimated $33M sold.

Gardner Lewis Asset Management first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $33M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Gardner Lewis Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 629,772 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $33M.
  • Gardner Lewis Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Gardner Lewis Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $33M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Gardner Lewis Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.